These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 23701429)

  • 1. SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours.
    Conner JR; Hornick JL
    Histopathology; 2013 Jul; 63(1):36-49. PubMed ID: 23701429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Special AT-rich sequence-binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high-grade primary bone sarcomas.
    Davis JL; Horvai AE
    Histopathology; 2016 Jul; 69(1):84-90. PubMed ID: 26644288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YJ5 as an immunohistochemical marker of osteogenic lineage.
    Chua K; Virshup DM; Odono EG; Chang KTE; Tan NJH; Hue SS; Sim AYL; Lee VKM
    Pathology; 2021 Feb; 53(2):229-238. PubMed ID: 33187685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of SATB2 in the pathologic diagnosis of osteosarcoma].
    Li M; Cai YP; Lu KY; Chen Y; Zhu X; Yin Y; Tang J
    Zhonghua Bing Li Xue Za Zhi; 2016 Sep; 45(9):631-5. PubMed ID: 27646893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours: comment on Conner et al. (2013).
    Creytens D; Ferdinande L
    Histopathology; 2015 Aug; 67(2):272-3. PubMed ID: 25469978
    [No Abstract]   [Full Text] [Related]  

  • 6. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
    Machado I; Navarro S; Picci P; Llombart-Bosch A
    Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoid osteoma and osteoblastoma: novel histological and immunohistochemical observations as evidence for a single entity.
    Barlow E; Davies AM; Cool WP; Barlow D; Mangham DC
    J Clin Pathol; 2013 Sep; 66(9):768-74. PubMed ID: 23814261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SATB2 is a novel marker of osteoblastic differentiation and colorectal adenocarcinoma.
    Ordóñez NG
    Adv Anat Pathol; 2014 Jan; 21(1):63-7. PubMed ID: 24316906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear p63 expression in osteoblastic tumors.
    Kallen ME; Sanders ME; Gonzalez AL; Black JO; Keedy VL; Hande KR; Homlar KC; Halpern JL; Holt GE; Schwartz HS; Coffin CM; Cates JM
    Tumour Biol; 2012 Oct; 33(5):1639-44. PubMed ID: 22623071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of SATB2 in primary cutaneous sarcomatoid neoplasms: a potential diagnostic pitfall.
    Szczepanski JM; Siddiqui J; Patel RM; Harms PW; Hrycaj SM; Chan MP
    Pathology; 2023 Apr; 55(3):350-354. PubMed ID: 36732203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of MDM2, CDK4 and SATB2 immunohistochemistry in histologic diagnosis of low-grade osteosarcoma].
    Chen CY; Zhang HZ; Jiang ZM; Zhou J; Chen J; Liu L
    Zhonghua Bing Li Xue Za Zhi; 2016 Jun; 45(6):387-92. PubMed ID: 27256046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical identification of osteogenic bone tumors by osteonectin antibodies.
    Jundt G; Schulz A; Berghäuser KH; Fisher LW; Gehron-Robey P; Termine JD
    Virchows Arch A Pathol Anat Histopathol; 1989; 414(4):345-53. PubMed ID: 2496522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of immunohistochemical cyclo-oxygenase-2 (COX-2) and osteocalcin in differentiating between osteoblastomas and osteosarcomas.
    El-Badawi ZH; Muhammad EM; Noaman HH
    Malays J Pathol; 2012 Jun; 34(1):15-23. PubMed ID: 22870593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoid osteoma: the uniquely innervated bone tumor.
    O'Connell JX; Nanthakumar SS; Nielsen GP; Rosenberg AE
    Mod Pathol; 1998 Feb; 11(2):175-80. PubMed ID: 9504688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sox9 expression is not limited to chondroid neoplasms: variable occurrence in other soft tissue and bone tumors with frequent expression by synovial sarcomas.
    Cajaiba MM; Jianhua Luo ; Goodman MA; Fuhrer KA; Rao UN
    Int J Surg Pathol; 2010 Oct; 18(5):319-23. PubMed ID: 20484142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin synthesis by osteoid osteoma and osteoblastoma.
    Wold LE; Pritchard DJ; Bergert J; Wilson DM
    Mod Pathol; 1988 Mar; 1(2):129-31. PubMed ID: 3266336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SATB2 Expression Is Sensitive but Not Specific for Osteosarcomatous Components of Gynecologic Tract Carcinosarcomas: A Clinicopathologic Study of 60 Cases.
    Sangoi AR; Kshirsagar M; Horvai AE; Roma AA
    Int J Gynecol Pathol; 2017 Mar; 36(2):140-145. PubMed ID: 27294605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p63 expression in giant cell-containing lesions of bone and soft tissue.
    de la Roza G
    Arch Pathol Lab Med; 2011 Jun; 135(6):776-9. PubMed ID: 21631272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteocalcin and osteonectin immunoreactivity in extraskeletal osteosarcoma: a study of 28 cases.
    Fanburg-Smith JC; Bratthauer GL; Miettinen M
    Hum Pathol; 1999 Jan; 30(1):32-8. PubMed ID: 9923924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-type amino acid transporter-1 and CD98 expression in bone and soft tissue tumors.
    Koshi H; Sano T; Handa T; Yanagawa T; Saitou K; Nagamori S; Kanai Y; Takagishi K; Oyama T
    Pathol Int; 2015 Sep; 65(9):460-7. PubMed ID: 26134029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.